Effect of injection of different doses of isoproterenol on the hearts of mice

BMC Cardiovasc Disord. 2022 Sep 12;22(1):409. doi: 10.1186/s12872-022-02852-x.

Abstract

Background: Heart failure (HF) is one of the diseases that seriously threaten human health today and its mechanisms are very complex. Our study aims to confirm the optimal dose ISO-induced chronic heart failure mice model for better study of HF-related mechanisms and treatments in the future.

Methods: C57BL/6 mice were used to establish mice model of chronic heart failure. We injected isoproterenol subcutaneously in a dose gradient of 250 mg/kg, 200 mg/kg, 150 mg/kg, 100 mg/kg and 50 mg/kg. Echocardiography and ELISA were performed to figure out the occurrence of HF. We also supplemented the echocardiographic changes in mice over 30 days.

Results: Except group S and group E, echocardiographic abnormalities were found in other groups, suggesting a decrease in cardiac function. Except group S, myofibrolysis were found in the hearts of mice in other groups. Brain natriuretic peptide was significantly increased in groups B and D, and C-reactive protein was significantly increased in each group.

Conclusion: Our research finally found that the HFrEF mice model created by injection at a dose of 100 mg/kg for 7 days was the most suitable and a relatively stable chronic heart failure model could be obtained by placing it for 21 days.

Keywords: Animal model; Dosage standards; Heart failure; Isoproterenol; Modeling success criteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Heart
  • Heart Failure* / chemically induced
  • Heart Failure* / drug therapy
  • Heart Failure* / metabolism
  • Humans
  • Isoproterenol
  • Mice
  • Mice, Inbred C57BL
  • Stroke Volume

Substances

  • Isoproterenol